Logotype for Freemelt Holding

Freemelt (FREEM) Q1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Freemelt Holding

Q1 2025 earnings summary

21 Nov, 2025

Executive summary

  • Q1 2025 focused on revenue streams, business model evolution, and new shareholder interests, with core E-PBF 3D printing technology targeting defense, energy, and medtech sectors.

  • Rights issue raised SEK 90 million, with potential for SEK 53 million more via warrants in 2026, strengthening financial position.

  • Record-high order book of SEK 19.3 million at quarter end, up from SEK 3 million year-over-year, driven by new project and machine orders.

  • Strategic progress in defense and energy, including new orders from Saab Dynamics, UKAEA, and expanded collaborations in fusion energy and MedTech.

  • Customer base expanding from academia to industry, with new industrial machine (eMELT) launched and feasibility studies underway.

Financial highlights

  • Q1 2025 net sales were SEK 2.9 million, mainly from projects and aftermarket; no machine deliveries occurred in the quarter.

  • Net sales for Q1 2025 were SEK 2,926k, up from SEK 816k in Q1 2024.

  • Operating result was SEK -24,084k (Q1 2024: SEK -23,439k); result after financial items SEK -24,056k.

  • Cash at bank at period end was SEK 71,822k (Q1 2024: SEK 17,460k), with cash flow for the period at SEK 55,355k, mainly due to the rights issue.

  • Record high order book at SEK 19.3 million, primarily composed of machine orders.

Outlook and guidance

  • Strong demand expected to continue in defense and energy, supported by geopolitical trends and EU defense ramp-up.

  • Focus remains on advancing additive manufacturing in defense, energy, and MedTech sectors, with ongoing collaborations and feasibility studies positioning for future serial production contracts.

  • Anticipates further growth in order book and conversion to sales as projects and machine deliveries progress.

  • Market trends in fusion energy and MedTech expected to drive demand.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more